Sword Health Stock

Sword Health is a digital musculoskeletal therapy provider that pairs its members with a licensed physical therapist.

Sign up today and learn more about Sword Health Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Sword Health Stock

Sword Health, the world’s fastest growing digital musculoskeletal (MSK) company, believes in the power of people to recover at home, without resorting to imaging, surgeries or opioids. As the first digital solution to pair its members with a licensed physical therapist and the Digital Therapist, Sword delivers a clinically-proven, personalized treatment plan that is easier, more effective and less expensive than the traditional gold standard of care. Now, Sword has expanded into new categories, as part of its mission to free two billion people from pain. Earlier this year it launched Bloom, the first digital pelvic health therapy solution designed to treat the 1 in 4 women who suffer from a pelvic health condition. As of November 2022, Sword is now pioneering a new category of movement health, which combines the focused approach of physical therapy with the whole body appeal of fitness. Every Sword solution leverages technology and human expertise to deliver better engagement and outcomes than traditional healthcare methods. Since entering the market in 2020, Sword Health has worked with insurers, health systems, and employers in the U.S., Canada, Europe, and Australia to make high quality musculoskeletal care, and beyond, accessible to everyone.


Funding History

April 2015$1.3M
July 2015$1.3M
April 2018$4.6M
April 2019$8.0M
February 2020$9.0M
January 2021$25.0M
June 2021$85.0M
November 2021$163M
November 2021$26.0M


Founder & CEO

Virgílio Bento


Fernando Correia

Founder, CSO

Márcio Colunas

VP of Strategic Business Development

André Santos

VP, Commercial

Kyle Spackman

EVP, Partnerships

Neil Sharma

Chief People Officer

Pavle Stojkovic

Recruiting Manager

Jason Nussbaum

Strategic Advisory Board

Scott Rotermund

Chief Experience Officer

Natasha Prasad

VP, Clinical Operations

Alexandre Droulers


Valentina Longo

VP of Product

Ivo Gabriel

Regulatory Affairs Officer

Catarina Prata

VP of Algorithms and AI

Luis Ungaro

VP of Engineering

Jorge Meireles

Senior Manager of Sales Enablement

Jose Alejandro Montero

Chief Talent Officer

Thach Nguyen

VP, Finance

Scott Albrecht

Senior Vice President, Customer Success

Kris Davis

Android Developer

António Vieira


David Hong

VP of Hardware Products

Daipan Lee

Director of Clinical Operations

André Nogueira

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: